Selected research
Industry Growth & Trends
Global Lidocaine Transdermal Patch Industry Growth and Trends Forecast to 2032
Market perspective
The global Lidocaine Transdermal Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lidocaine Transdermal Patch include Teva Pharmaceutical, Tide Pharmaceutical (SINO BIOPHARM), Mylan, Teikoku, Sorrento Therapeutics, Par Pharmaceutical, Hisamitsu and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Lidocaine Transdermal Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Lidocaine Transdermal Patch market size, estimates, and forecasts are presented in terms of sales volume (m pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lidocaine Transdermal Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lidocaine Transdermal Patch.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Lidocaine Transdermal Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Lidocaine Transdermal Patch Market by Company
Teva Pharmaceutical
Tide Pharmaceutical (SINO BIOPHARM)
Mylan
Teikoku
Sorrento Therapeutics
Par Pharmaceutical
Hisamitsu
Endo International
Lidocaine Transdermal Patch Segment by Type
Lidocare 1.80% Transdermal Patch
Lidocare 5% Transdermal Patch
Lidocare 4% Transdermal Patch
Lidocaine Transdermal Patch Segment by Application
Clinic
Hospital Pharmacies
Online Pharmacies
Chain Pharmacies
Monomer Pharmacies
Other
Lidocaine Transdermal Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Lidocaine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lidocare 1.80% Transdermal Patch
- Lidocare 5% Transdermal Patch
- Lidocare 4% Transdermal Patch
Applications
- Clinic
- Hospital Pharmacies
- Online Pharmacies
- Chain Pharmacies
- Monomer Pharmacies
- Other
Companies covered
- Teva Pharmaceutical
- Tide Pharmaceutical (SINO BIOPHARM)
- Mylan
- Teikoku
- Sorrento Therapeutics
- Par Pharmaceutical
- Hisamitsu
- Endo International
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Lidocaine Transdermal Patch Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Lidocaine Transdermal Patch Sales Estimates and Forecasts (2021-2032)
- 1.3 Lidocaine Transdermal Patch Market by Type
- 1.3.1 Lidocare 1.80% Transdermal Patch
- 1.3.2 Lidocare 5% Transdermal Patch
- 1.3.3 Lidocare 4% Transdermal Patch
- 1.4 Global Lidocaine Transdermal Patch Market Size by Type
- 1.4.1 Global Lidocaine Transdermal Patch Market Size Overview by Type (2021-2032)
- 1.4.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Lidocaine Transdermal Patch Industry Trends
- 2.2 Lidocaine Transdermal Patch Industry Drivers
- 2.3 Lidocaine Transdermal Patch Industry Opportunities and Challenges
- 2.4 Lidocaine Transdermal Patch Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Lidocaine Transdermal Patch Revenue (2021-2026)
- 3.2 Global Top Players by Lidocaine Transdermal Patch Sales (2021-2026)
- 3.3 Global Top Players by Lidocaine Transdermal Patch Price (2021-2026)
- 3.4 Global Lidocaine Transdermal Patch Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lidocaine Transdermal Patch Major Company Production Sites & Headquarters
- 3.6 Global Lidocaine Transdermal Patch Company, Product Type & Application
- 3.7 Global Lidocaine Transdermal Patch Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lidocaine Transdermal Patch Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lidocaine Transdermal Patch Players Market Share by Revenue in 2025
- 3.8.3 2025 Lidocaine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Lidocaine Transdermal Patch Regional Status and Outlook
- 4.1 Global Lidocaine Transdermal Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Lidocaine Transdermal Patch Historic Market Size by Region
- 4.2.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2021-2026)
- 4.2.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2021-2026)
- 4.2.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Region
- 4.3.1 Global Lidocaine Transdermal Patch Sales in Volume by Region (2027-2032)
- 4.3.2 Global Lidocaine Transdermal Patch Sales in Value by Region (2027-2032)
- 4.3.3 Global Lidocaine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lidocaine Transdermal Patch by Application
- 5.1 Lidocaine Transdermal Patch Market by Application
- 5.1.1 Clinic
- 5.1.2 Hospital Pharmacies
- 5.1.3 Online Pharmacies
- 5.1.4 Chain Pharmacies
- 5.1.5 Monomer Pharmacies
- 5.1.6 Other
- 5.2 Global Lidocaine Transdermal Patch Market Size by Application
- 5.2.1 Global Lidocaine Transdermal Patch Market Size Overview by Application (2021-2032)
- 5.2.2 Global Lidocaine Transdermal Patch Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Lidocaine Transdermal Patch Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Lidocaine Transdermal Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva Pharmaceutical
- 6.1.1 Teva Pharmaceutical Company Information
- 6.1.2 Teva Pharmaceutical Business Overview
- 6.1.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
- 6.1.5 Teva Pharmaceutical Recent Developments
- 6.2 Tide Pharmaceutical (SINO BIOPHARM)
- 6.2.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
- 6.2.2 Tide Pharmaceutical (SINO BIOPHARM) Business Overview
- 6.2.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
- 6.2.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
- 6.3 Mylan
- 6.3.1 Mylan Company Information
- 6.3.2 Mylan Business Overview
- 6.3.3 Mylan Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan Lidocaine Transdermal Patch Product Portfolio
- 6.3.5 Mylan Recent Developments
- 6.4 Teikoku
- 6.4.1 Teikoku Company Information
- 6.4.2 Teikoku Business Overview
- 6.4.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
- 6.4.5 Teikoku Recent Developments
- 6.5 Sorrento Therapeutics
- 6.5.1 Sorrento Therapeutics Company Information
- 6.5.2 Sorrento Therapeutics Business Overview
- 6.5.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
- 6.5.5 Sorrento Therapeutics Recent Developments
- 6.6 Par Pharmaceutical
- 6.6.1 Par Pharmaceutical Company Information
- 6.6.2 Par Pharmaceutical Business Overview
- 6.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
- 6.6.5 Par Pharmaceutical Recent Developments
- 6.7 Hisamitsu
- 6.7.1 Hisamitsu Company Information
- 6.7.2 Hisamitsu Business Overview
- 6.7.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
- 6.7.5 Hisamitsu Recent Developments
- 6.8 Endo International
- 6.8.1 Endo International Company Information
- 6.8.2 Endo International Business Overview
- 6.8.3 Endo International Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Endo International Lidocaine Transdermal Patch Product Portfolio
- 6.8.5 Endo International Recent Developments
7 North America by Country
- 7.1 North America Lidocaine Transdermal Patch Sales by Country
- 7.1.1 North America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Lidocaine Transdermal Patch Sales by Country (2021-2026)
- 7.1.3 North America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
- 7.2 North America Lidocaine Transdermal Patch Market Size by Country
- 7.2.1 North America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Lidocaine Transdermal Patch Market Size by Country (2021-2026)
- 7.2.3 North America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Lidocaine Transdermal Patch Sales by Country
- 8.1.1 Europe Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Lidocaine Transdermal Patch Sales by Country (2021-2026)
- 8.1.3 Europe Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
- 8.2 Europe Lidocaine Transdermal Patch Market Size by Country
- 8.2.1 Europe Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Lidocaine Transdermal Patch Market Size by Country (2021-2026)
- 8.2.3 Europe Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Lidocaine Transdermal Patch Sales by Country
- 9.1.1 Asia-Pacific Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Lidocaine Transdermal Patch Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country
- 9.2.1 Asia-Pacific Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Lidocaine Transdermal Patch Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Lidocaine Transdermal Patch Sales by Country
- 10.1.1 South America Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Lidocaine Transdermal Patch Sales by Country (2021-2026)
- 10.1.3 South America Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
- 10.2 South America Lidocaine Transdermal Patch Market Size by Country
- 10.2.1 South America Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Lidocaine Transdermal Patch Market Size by Country (2021-2026)
- 10.2.3 South America Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Lidocaine Transdermal Patch Sales by Country
- 11.1.1 Middle East and Africa Lidocaine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Lidocaine Transdermal Patch Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country
- 11.2.1 Middle East and Africa Lidocaine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Lidocaine Transdermal Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Lidocaine Transdermal Patch Value Chain Analysis
- 12.1.1 Lidocaine Transdermal Patch Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Lidocaine Transdermal Patch Production Mode & Process
- 12.2 Lidocaine Transdermal Patch Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Lidocaine Transdermal Patch Distributors
- 12.2.3 Lidocaine Transdermal Patch Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst